The Inflation Reduction Act Aims To Lower Drug Costs — But Here’s How Big Pharma Could Get Around It
The Inflation Reduction Act is set to lower drug prices for millions of people in the U.S. — but experts fear pharmaceutical companies could exploit loopholes in the bill, ultimately keeping prescription costs high for many. The law takes aim at insulin costs, caps out-of-pocket spending for Medicare beneficiaries, and allows the federal government to ...
With current COVID-19 Supplemental Paid Sick Leave (SPSL) requirements set to expire on September 30, the California Legislature has passed California Assembly Bill 152 (AB 152), which now awaits Governor Gavin Newsom’s signature.
Businesses continue to struggle with ever-rising healthcare costs with 7 in 10 employers expecting moderate to significant increases in what they pay for healthcare benefits over the next three years.
Two weeks after the CDC and FDA authorized Moderna's bivalent omicron booster for emergency use, doses are running out in a few U.S. states.
With 400 to 500 Americans still dying every day of Covid-19, President Biden has declared that “the pandemic is over.”
Have you been wondering whether long COVID was a true post-virus symptom? Now it has been officially confirmed – because researchers have put a price tag on what its costing employer sponsored health plans.